SorafenibErythrodysaesthesia and squamous cell cancer: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2011年 / 1339卷 / 1期

关键词：

Public Health; Signaling Pathway; Squamous Cell; Patient Outcome; Congenital Anomaly;

D O I：

10.2165/00128415-201113390-00117

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：36 / 36

相关论文

共 50 条

[1] SorafenibErythrodysaesthesia: case report
Reactions Weekly, 2011, 1343 (1) : 28 - 28
[2] SorafenibErythrodysaesthesia: case report
Reactions Weekly, 2011, 1369 (1) : 35 - 35
[3] SorafenibErythrodysaesthesia: case report
Reactions Weekly, 2011, 1382 (1) : 31 - 31
[4] SorafenibErythrodysaesthesia, alopecia, nausea and diarrhoea: case report
Reactions Weekly, 2008, 1199 (1) : 42 - 42
[5] Tetanus vaccineFirst report of squamous cell cancer: case report
Reactions Weekly, 2008, 1225 (1) : 26 - 26
[6] SorafenibErythrodysaesthesia in an elderly patient: case report
Reactions Weekly, 2012, 1393 (1) : 38 - 38
[7] EtanerceptCutaneous squamous cell cancer of the penis: case report
Reactions Weekly, 2005, 1036 (1) : 9 - 9
[8] Transverse colon squamous cell cancer: Case report
Quiroga-Echeverri, Alicia
Gonzalez-Perez, Luis Gabriel
Durango, Isabel Cristina
Hoyos, Sergio Ivan
Arango-Rivas, Ana Maria
REVISTA COLOMBIANA DE CANCEROLOGIA, 2023, 27 (02): : 260 - 264
[9] SorafenibFirst report of actinic keratosis and squamous cell cancer: 2 case reports
Reactions Weekly, 2007, 1133 (1) : 24 - 24
[10] AzathioprineOral squamous cell carcinoma: case report
Reactions Weekly, 2012, 1418 (1) : 12 - 12

← 1 2 3 4 5 →